Abstract: In a passenger seating arrangement in an aircraft cabin, the passenger seating arrangement has exactly two rows of seat units and exactly one aisle. A first row of seat units and a second row of seat units are separated by the aisle. The rows of seat units and the aisle all extend in a longitudinal direction parallel to a longitudinal axis of the aircraft cabin. Each seat unit includes a seat, an upper shell and a lower shell, the lower shell forming a footwell. The seats are arranged in parallel to each other in a seating direction. An upper shell of a first seat unit and a lower shell of a second seat unit, which, viewed in the longitudinal direction, is arranged behind the first seat unit, partially overlap in a vertical direction.

Abstract: A passenger seating arrangement in an aircraft cabin, the passenger seating arrangement comprising exactly two rows of seat units and exactly one aisle, wherein a first row of seat units and a second row of seat units are separated by the aisle, and wherein the rows of seat units and the aisle all extend in a longitudinal direction parallel to a longitudinal axis of the aircraft cabin, each seat unit comprising a seat, an upper shell and a lower shell, the lower shell forming a footwell, wherein the seats are arranged in parallel to each other in a seating direction, wherein an upper shell of a first seat unit and a lower shell of a second seat unit, which, viewed in the longitudinal direction, is arranged behind the first seat unit, partially overlap in a vertical direction.

Abstract: This invention relates to methods for inhibiting growth of anaerobic bacteria, particularly halitosis causing bacteria. The methods use BLIS-producing Streptococcus salivarius strains, extracts thereof, and compositions comprising same in the prevention or treatment of halitosis.

Abstract: This invention provides novel Streptococcus salivarius, compositions containing same, and use of S. salivarius strains as antimicrobial agents. The strains are bacterial inhibitors with respect to at least S. mutans and/or MS and therefore have a number of therapeutic applications. The applications include but are not limited to forming part of therapeutic formulations for use in controlling, treating, or preventing dental caries.